This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Cholecystitis is a condition that causes inflammation of the gallbladder. It is usually caused by gallstones blocking the outflow of bile from the gallbladder. The majority of cholecystitis cases are caused by the presence of gallstones. Other causes include infection, trauma, or tumors. Symptoms include abdominal pain, nausea, vomiting, and sometimes fever. The diagnosis of cholecystitis is typically confirmed using imaging tests such as an abdominal ultrasound or computed tomography (CT) scan. Treatment typically involves removal of the gallbladder, which is known as a cholecystectomy. This procedure is usually done laparoscopically, meaning through small incisions in the abdomen. After a cholecystectomy, the bile that is normally stored in the gallbladder is redirected to the small intestines, where it helps the body digest fat and absorb fat-soluble vitamins. The removal of the gallbladder does not typically affect a person’s ability to digest food. Complications can occur following cholecystectomy, especially if the gallbladder was infected. Infection can spread to the abdomen and cause a condition known as peritonitis, which can be life-threatening. Other possible complications include bleeding, infection, and injury to nearby organs. Cholecystitis can be prevented by maintaining a healthy weight, avoiding fatty and greasy foods, and drinking plenty of fluids. It is also important to seek medical attention if you experience any of the symptoms of cholecystitis, such as abdominal pain, nausea, or vomiting.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States